MENA 2024 Recordings-Evaluation and Management of Thyroid Nodules

Video Transcription

Video Summary

The speaker addresses advancements in diagnosing and managing thyroid nodules, particularly acknowledging past limitations and improvements in risk assessment over recent decades. Traditional methods, like biopsies of nodules over one centimeter, are deemed suboptimal due to risks of over-diagnosis. The presentation highlights emerging strategies incorporating demographic, radiographic, cytologic, and molecular analyses, including molecular testing to assess cancer risk more accurately. The importance of understanding demographic risk factors, such as age and sex, as well as the limitations of ultrasound and cytology, is emphasized. Furthermore, the talk touches on molecular analysis, particularly RNA-based tests and their efficacy in evaluation. The future consideration includes integrated care through multimodal risk assessment, combining these tools to provide personalized patient care. Lastly, the potential impact of artificial intelligence in interpreting ultrasounds and cytology is noted as a field of future growth in thyroid nodule management.

Asset Subtitle

Dr. Erik Alexander

Keywords

thyroid nodules

molecular testing

risk assessment

artificial intelligence

personalized care

RNA-based tests